Summary of this trial
This Phase 4 trial in patients with Critical Stenosis of Aortic Valve is being sponsored by Seoul National University Hospital. 100 individuals will be dosed with one or more of the following: Fimasartan. Trial dates are from 1st April 2012 to 1st December 2014. The study is currently recruiting.